Private Wealth Management Group’s Amicus Therapeutics FOLD Stock Holding History

Private Wealth Management Group’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-102	Closed	-$1.48K	–	1478
2026 Q1	$1.48K	Hold	102	–	–	﹤0.01%	1170
2025 Q4	$1.45K	Hold	102	–	–	﹤0.01%	1177
2025 Q3	$804	Hold	102	–	–	﹤0.01%	1328
2025 Q2	$585	Buy	+102	New	+$658	﹤0.01%	1396
2024 Q2	–	Sell	-84	Closed	-$990	–	1545
2024 Q1	$990	Hold	84	–	–	﹤0.01%	1269
2023 Q4	$1.19K	Buy	+84	New	+$954	﹤0.01%	1198

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Private Wealth Management Group's FOLD Position: Q2 2026 in Review

Private Wealth Management Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 102 shares — an estimated $1.48K sold.

Private Wealth Management Group first reported a position in FOLD in Q4 2023 and held it in 6 quarters. The position peaked at $1.48K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Private Wealth Management Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Private Wealth Management Group sold 102 Amicus Therapeutics shares in Q2 2026, an estimated $1.48K.
Private Wealth Management Group first reported a position in Amicus Therapeutics in Q4 2023 and held it in 6 quarters.
Private Wealth Management Group's Amicus Therapeutics position peaked at $1.48K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.